Celera Shifts Focus To Clinical Diagnostics, Deserting Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
In revamping its business strategy away from drug development, the biotech firm assumes sole ownership of Celera Diagnostics from sister company Applied Biosystems.